Management strategy for gastric cancer with liver cirrhotic portal hypertension
2012-08-15PanMing
/Pan Ming
(潘明,Dept Gen Surg,Peop Hosp Shanghai Jiaotong Univ,Shanghai 200020)…∥Chin JGen Surg.-2011,14(8).-674~676
ObjectiveTo assess the concurrent management for portal hypertension(PHT)in gastric cancer patients.MethodsRetrospective analysis was made on 60 cases of gastric cancer occurring on the background of cirrhotic PHT,of which 30 cases were of Child A grade,and 30 patients were Child B class.Ten cases were on gastric cancer stageⅠ,38 cases on stageⅡ and 12 cases were on stageⅢ.Radical gastrectomy plus splenectomy and devascularization were performed in 26 cases,while radical gastrectomy only was done in 34 cases.ResultsPostoperative Child-Pugh degrading developed in 100%cases undergoing combined procedures;while in the 34 cases undergoing radical gastrectomy only,postoperative degradation from the preoperative Child-Pugh classification occurred in 7 cases(20%),P <0.001.In this series the peri-operative mortality was 3%,all were patients at stageⅢgastric cancer combined with Child-Pugh class B.ConclusionThe principle of treatment for gastric cancer with cirrhotic portal hypertension is restrictive surgery.The main purpose is to cure cancer and not to damage liver function.8 refs,3 tabs.
杂志排行
外科研究与新技术的其它文章
- Value of diffusion-weighted MR imaging and dynamic-contrast enhanced MRI in the diagnosis of breast cancer
- Meta-analysis of the efficacy between gemcitabine-alone and gemcitabine-based chemotherapy applied to advanced pancreatic cancer
- Effect of decompression in different time on hemodynamics and oxygen metabolism of porcine model with severe acute pancreatitis combined intraabdominal hypertension
- Postoperative use of Sorafenib in liver transplantation patients of hepatocellular carcinoma beyond Milan criteria
- Combined liver-kidney transplantation and orthotopic liver transplantation in the treatment of severe hepatitis B
- HO-1 up-regulation decreases liver ischemia/reperfusion injury by inhibiting mast cells degranulation
